Accelerating its move into cell and gene therapy services, Catalent will acquire Delphi Genetics, a drug services firm specializing in plasmid DNA (pDNA). Delphi operates a 1,600 m 2 facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results